ArticlePloS one2017

Dynamical models of mutated chronic myelogenous leukemia cells for a post-imatinib treatment scenario: Response to dasatinib or nilotinib therapy.

Clemens Woywod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.